Higher Order Structure Differences Among Insulin Crystalline Drugs Revealed by 2D heteronuclear NMR
- 30 September 2024
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 19 (23) , e202400340
Abstract
During therapeutic protein development, two‐dimensional (2D) heteronuclear NMR spectra can be a powerful analytical method for measuring protein higher order structure (HOS) in solution since the spectra exhibit much higher resolution than homonuclear 1H spectra. However, 2D NMR capabilities for characterizing protein HOS in crystalline states remain to be assessed, given the low 13C natural abundance and intrinsically broader lines in solid‐state NMR (SSNMR). Herein, high‐resolution heteronuclear correlation (HETCOR) SSNMR was utilized to directly measure intact crystal drug products of insulin human, insulin analogs of insulin lispro and insulin aspart. The fingerprint regions in 2D 1H−13C HETCOR spectra were identified, which distinguished the insulin crystals in their primary structure, HOS heterogeneity and dynamics, as well as the manufacturing processes. The HOS heterogeneity in insulin analogs is consistent with their therapeutic effect of rapid action; while insulin human crystals showed more structural homogeneity, consistent with their slower pharmacokinetics (PK) peak time than insulin analogs. Therefore, heteronuclear NMR could be broadly applicable to study protein drug dosage forms from liquid to solid, yielding improved molecular level structure data for assessing drug HOS in biosimilar drug development.Keywords
Funding Information
- National Institutes of Health (R24GM141526)
This publication has 33 references indexed in Scilit:
- Evolution of CPMAS under fast magic-angle-spinning at 100 kHz and beyondSolid State Nuclear Magnetic Resonance, 2015
- Modern analytics for naturally derived complex drug substances: NMR and MS tests for protamine sulfate from chum salmonAnalytical and Bioanalytical Chemistry, 2014
- Effects of Phenol and meta-Cresol Depletion on Insulin Analog Stability at Physiological TemperatureJournal of Pharmaceutical Sciences, 2014
- Structural meta-analysis of regular human insulin in pharmaceutical formulationsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- A T3R3 hexamer of the human insulin variant B28AspBiophysical Chemistry, 2013
- Proton‐Detected Solid‐State NMR Spectroscopy of Natural‐Abundance Peptide and Protein PharmaceuticalsAngewandte Chemie International Edition, 2009
- Crystal structure of Ultralente—A microcrystalline insulin suspensionProteins: Structure, Function, and Bioinformatics, 2008
- Structural characterization of insulin NPH formulationsEuropean Journal of Pharmaceutical Sciences, 2007
- Molecular variants and derivatives of insulin for improved glycemic control in diabetesProgress in Biophysics and Molecular Biology, 2006
- Insulins today and beyondThe Lancet, 2001